Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Jul;58(1):22-33.
doi: 10.1080/00029157.2015.1025355.

Hypnotherapy for Esophageal Disorders

Affiliations
Case Reports

Hypnotherapy for Esophageal Disorders

Megan E Riehl et al. Am J Clin Hypn. 2015 Jul.

Abstract

Hypnotherapy is an evidence based intervention for the treatment of functional bowel disorders, particularly irritable bowel syndrome. While similar in pathophysiology, less is known about the utility of hypnotherapy in the upper gastrointestinal tract. Esophageal disorders, most of which are functional in nature, cause painful and uncomfortable symptoms that impact patient quality of life and are difficult to treat from a medical perspective. After a thorough medical workup and a failed trial of proton pump inhibitor therapy, options for treatment are significantly limited. While the pathophysiology is likely multifactorial, two critical factors are believed to drive esophageal symptoms--visceral hypersensitivity and symptom hypervigilance. The goal of esophageal directed hypnotherapy is to promote a deep state of relaxation with focused attention allowing the patient to learn to modulate physiological sensations and symptoms that are not easily addressed with conventional medical intervention. Currently, the use of hypnosis is suitable for dysphagia, globus, functional chest pain/non-cardiac chest pain, dyspepsia, and functional heartburn. In this article the authors will provide a rationale for the use of hypnosis in these disorders, presenting the science whenever available, describing their approach with these patients, and sharing a case study representing a successful outcome.

Keywords: behavioral medicine; esophageal disorders; gastroesophageal reflux disease; heartburn; hypnosis.

PubMed Disclaimer

References

    1. Atluri D, Chandar AK, Fass R, Falck-Ytter Y. Systematic review with meta-analysis: Selective serotonin reuptake inhibitors for noncardiac chest pain. Alimentary Pharmacology & Therapeutics. 2015;41:167–176. doi:10.1111/apt.13015. - PubMed
    1. Button LL, Russell DG, Klein HL, Medina-Acosta E, Karess RE, McMaster WR. Genes encoding the major surface glycoprotein in Leishmania are tandemly linked at a single chromosomal locus and are constitutively transcribed. Molecular and Biochemical Parasitology. 1989;32:271–283. doi:10.1016/0166-6851(89)90076-5. - PubMed
    1. Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002;123:1778–1785. doi:10.1053/gast.2002.37071. - PubMed
    1. Chiarioni G, Vantini I, De Iorio F, Benini L. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Alimentary Pharmacology and Therapeutics. 2006;23:1241–1249. doi:10.1111/apt.2006.23.issue-8. - PubMed
    1. Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology. 1987;92:1027–1036. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources